Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Genus Biotech is an Italian biotechnology company and a spin-off from the University of Salerno, specializing in molecular diagnostics and pharmacogenomics. The company focuses on the development of innovative genomic tools and biomarkers for personalized medicine, particularly in the fields of oncology and genetic disorders. Genus Biotech provides high-throughput sequencing and bioinformatics services to support clinical research and diagnostic applications. Its research initiatives include the identification of novel biomarkers for cancer prognosis and the development of diagnostic kits for predicting therapeutic responses in patients. The company leverages its expertise in molecular biology to bridge the gap between academic research and clinical diagnostic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Genus Biotech.